Insider · CIK 0001194459

DOYLE WILLIAM F

Reports to the SEC for 6 companies · WINSTON SALEM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001194459

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-28	PROKPROKIDNEY CORP. · Director stock option (right to buy)A Award	Director	AAward	+135K sh	—	—	135,000
2026-03-03	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+258K sh	—	—	258,445
2026-03-03	NVCRNovoCure LtdA Award	Director, Executive Chairman	AAward	+200K sh	—	—	400,284
2026-03-03	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+30.1K sh	—	—	288,517
2026-03-03	NVCRNovoCure LtdA Award	Director, Executive Chairman	AAward	+200K sh	—	—	200,000
2026-03-03	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−50.6K sh	$12.79	−$646K	349,727
2026-03-03	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−21.3K sh	$13.43	−$286K	328,397
2025-05-29	PROKPROKIDNEY CORP. · Director stock option (right to buy)A Award	Director	AAward	+126K sh	—	—	125,862
2024-11-29	ELANElanco Animal Health IncA Award	Director	AAward	+18.2K sh	—	—	94,499
2024-05-30	PROKPROKIDNEY CORP. · Director stock option (right to buy)A Award	Director	AAward	+62.6K sh	—	—	62,558
2024-05-21	ELANElanco Animal Health IncP Purchase	Director	PPurchase	+15K sh	$16.98	+$255K	76,330
2024-03-08	ELANElanco Animal Health IncP Purchase	Director	PPurchase	+15K sh	$16.30	+$245K	61,330
2023-11-30	ELANElanco Animal Health IncA Award	Director	AAward	+20.4K sh	—	—	46,330
2023-06-29	PROKPROKIDNEY CORP. · Director Stock Option (right to buy)A Award	Director	AAward	+48.1K sh	—	—	48,128
2022-11-30	ELANElanco Animal Health IncA Award	Director	AAward	+18.6K sh	—	—	25,956
2022-08-02	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−837 sh	$69.66	−$58.3K	551,176
2022-07-11	PROKPROKIDNEY CORP. · Common Units in ProKidney LPA Award	Director	AAward	+1.51M sh	—	—	1,514,326
2022-07-11	PROKPROKIDNEY CORP. · Class B Ordinary SharesA Award	Director	AAward	+1.51M sh	—	—	1,514,326
2022-06-10	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2022-03-08	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−2,385 sh	$70.10	−$167K	552,013
2022-03-03	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director, Executive Chairman	AAward	+14.6K sh	$80.59	+$1.18M	14,581
2021-11-30	ELANElanco Animal Health IncA Award	Director	AAward	+7,307 sh	—	—	7,307
2021-08-02	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−995 sh	$149.38	−$149K	554,398
2021-06-11	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−2,555 sh	$203.25	−$519K	570,670
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−4,388 sh	$202.16	−$887K	573,225
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−4,125 sh	$201.55	−$831K	577,613
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−4,338 sh	$199.71	−$866K	581,738
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−10.6K sh	$198.98	−$2.1M	586,076
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−1,972 sh	$204.28	−$403K	568,698
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−13.6K sh	$197.83	−$2.69M	596,639
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−24.3K sh	$197.00	−$4.79M	610,251
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−8,814 sh	$196.07	−$1.73M	634,589
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−1,600 sh	$194.94	−$312K	643,403
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−2,090 sh	$193.57	−$405K	645,003
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−600 sh	$216.69	−$130K	555,393
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−1,900 sh	$192.52	−$366K	647,093
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−500 sh	$214.66	−$107K	555,993
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−1,500 sh	$213.35	−$320K	556,493
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−1,400 sh	$191.26	−$268K	648,993
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−600 sh	$211.28	−$127K	557,993
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−521 sh	$210.18	−$110K	558,593
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−2,200 sh	$209.34	−$461K	559,114
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−4,500 sh	$207.80	−$935K	561,314
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−1,284 sh	$206.35	−$265K	565,814
2021-04-13	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−1,600 sh	$205.43	−$329K	567,098
2021-04-01	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−7,928 sh	$134.12	−$1.06M	650,393
2021-03-31	NVCRNovoCure Ltd · Restricted Stock UnitsM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−9,259 sh	—	—	0
2021-03-31	NVCRNovoCure LtdM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+9,259 sh	$125.25	+$1.16M	658,321
2020-07-31	NVCRNovoCure LtdS Sale	Director, Executive Chairman	SSale	−896 sh	$76.39	−$68.4K	649,062

Recent filings

Accepted (ET)
May 294
DOYLE WILLIAM F0001193125-26-248249
SEC(opens sec.gov)
Mar 54
DOYLE WILLIAM F0001194459-26-000001
SEC(opens sec.gov)
Jun 24
DOYLE WILLIAM F0000950170-25-080261
SEC(opens sec.gov)
Dec 34
DOYLE WILLIAM F0001415889-24-028153
SEC(opens sec.gov)
Jun 34
DOYLE WILLIAM F0000950170-24-068038
SEC(opens sec.gov)
May 234
DOYLE WILLIAM F0001415889-24-014279
SEC(opens sec.gov)
Mar 124
DOYLE WILLIAM F0001415889-24-007635
SEC(opens sec.gov)
Dec 44
DOYLE WILLIAM F0001415889-23-015780
SEC(opens sec.gov)
Jul 34
DOYLE WILLIAM F0001209191-23-040419
SEC(opens sec.gov)
Dec 24
DOYLE WILLIAM F0001415889-22-011980
SEC(opens sec.gov)
Aug 34
DOYLE WILLIAM F0001645113-22-000071
SEC(opens sec.gov)
Jul 134
DOYLE WILLIAM F0000950103-22-012366
SEC(opens sec.gov)
Jun 284
DOYLE WILLIAM F0001209191-22-039688
SEC(opens sec.gov)
Mar 94
DOYLE WILLIAM F0001645113-22-000024
SEC(opens sec.gov)

Companies

Address

C/O PROKIDNEY CORP 2000 FRONTIS PLAZA BLVD, SUITE 250

WINSTON SALEM, NC, 27103